Avian Influenza Vaccine Companies

Q: What is the global market size of Avian Influenza Vaccine Market?

Global Avian Influenza Vaccine Market size was valued at USD 140.0 Billion in 2022 and is poised to grow from USD 145.88 Billion in 2023 to USD 202.74 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).

Q: Which region accounted for the largest share in Global Avian Influenza Vaccine Market?

The global avian influenza vaccine market is dominated by Asia Pacific. This can be attributed to increased poultry production and increasing outbreaks of bird flu in the region. China produced 13,900 thousand metric tons of poultry meat in 2022, according to a recent Foreign Agricultural Service/USDA report, it is estimated that the U.S. will exhibit significant market growth due to growing meat and poultry industry, increasing animal health expenditure.

Avian Influenza Vaccine Market Competitive Landscape

The competitive environment of the Global Avian Influenza Vaccine Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor.

Top Player’s Company Profiles

Boehringer Ingelheim International GmbH (Germany)

Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)

Ceva (US)

Yebio Bioengineering Co., Ltd (China)

Zoetis (US)

FATRO S.P.A. (Italy)

CAVAC (South Korea)

Tianjin Ringpu Bio-Technology Co., Ltd (China)

PT Japfa Comfeed Indonesia Tbk (Indonesia)

Chengdu Tech-bank Biological Products Co., Ltd (China)

Merck Animal Health (US)

Medion (Indonesia)

Avimex Animal Health (Mexico)

JOVAC (Jordan)

QYH BIOTECH COMPANY LIMITED (China)

FAQs

Avian Influenza Vaccine Market size was valued at USD 140.0 Billion in 2022 and is poised to grow from USD 145.88 Billion in 2023 to USD 202.74 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).

The competitive environment of the Avian Influenza Vaccine Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Boehringer Ingelheim International GmbH (Germany)', 'Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)', 'Ceva (US)', 'Yebio Bioengineering Co., Ltd (China)', 'Zoetis (US)', 'FATRO S.P.A. (Italy)', 'CAVAC (South Korea)', 'Tianjin Ringpu Bio-Technology Co., Ltd (China)', 'PT Japfa Comfeed Indonesia Tbk (Indonesia)', 'Chengdu Tech-bank Biological Products Co., Ltd (China)', 'Merck Animal Health (US)', 'Medion (Indonesia)', 'Avimex Animal Health (Mexico)', 'JOVAC (Jordan)', 'QYH BIOTECH COMPANY LIMITED (China)'

Avian influenza can be defined as a disease caused by avian influenza virus type-A. This virus is commonly found in waterfowl and can infect domestic chickens and other bird species. Based on viral surface proteins, subtypes of influenza type A viruses can be classified into neuraminidase (NA) and hemagglutinin (HA). Based on their molecular characteristics and ability to cause disease and death in chicken avian influenza viruses are classified as highly pathogenic and low pathogenicity but both in poultry, high prevalence is reported. Nonpathogenic bird flu viruses show no signs of illness. Only mild diseases such as egg decline and wildflies show it. However, infection with the highly pathogenic influenza virus is associated with high mortality.

Along with Israel, China, India and South Korea have the highest number of bird flu viruses in Asia-Pacific. This is followed by rapid supply chain improvements and a growing R&D infrastructure through supportive government policies.

The avian influenza vaccine market is dominated by Asia Pacific. This can be attributed to increased poultry production and increasing outbreaks of bird flu in the region. China produced 13,900 thousand metric tons of poultry meat in 2022, according to a recent Foreign Agricultural Service/USDA report, it is estimated that the U.S. will exhibit significant market growth due to growing meat and poultry industry, increasing animal health expenditure.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Strain(H5, H7, and H9), By Application(Chicken, Turkey, and Goose & Duck), By Region - Industry Forecast 2024-2031

Avian Influenza Vaccine Market Competitive Landscape

Avian Influenza Vaccine Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Strain(H5, H7, and H9), By Application(Chicken, Turkey, and Goose & Duck), By Region - Industry Forecast 2024-2031

Avian Influenza Vaccine Market Competitive Landscape

Avian Influenza Vaccine Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Avian Influenza Vaccine Market?

Who are the key vendors in the Avian Influenza Vaccine Market?

What is the key driver of Avian Influenza Vaccine Market?

What is the key market trend for Avian Influenza Vaccine Market?

Which region accounted for the largest share in Avian Influenza Vaccine Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300